Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

All Party Parliamentary Group For Parkinson's Disease Announces Report & Parkinson's Disease Society Launches Fair Care For Parkinson's
When: 8 July 2009 6:00pm - 8:00pm
generic viagra online
Small Business Owners Deliver Mixed Messages To Capitol Hill
As more specific legislative language emerges on health care, "small business organizations are encouraging members to make their views known through e-mails, letters, phone calls and personal visits" to members of Congress, but "the message is a decidedly mixed one," Kaiser Health News reports. "Small business, a powerful constituency in every congressional district, no longer speaks with one voice on health care. Many of the bigger and more powerful groups that represent small businesses, including the National Federation of Independent Business (NFIB) and the U.S. Chamber of Commerce, have long been allied with Republicans and are lobbying hard against the public option and the employer mandate." But newer, less conservative groups, including the Main Street Alliance, are advocating for those same hot button issues.
plastic surgery before after
News of the day
ExonHit Announces Last Patient Out For EHT 0202 Phase IIa Study In Alzheimer's
ExonHit Therapeutics (Paris:ALEHT) announced that clinical testing of EHT 0202, its lead therapeutic compound in Alzheimer"s disease, is progressing well. Final patient dosing for the Phase IIa proof-of-concept clinical trial assessing EHT 0202 in patients with Alzheimer"s disease is completed.
Diagnostics

Glasgow Based BioOut Active In Flu Vaccine Testing

BioOut is a strategic partner for several of the world"s leading vaccine manufacturers. As such, BioOut is currently working with partners on projects to develop vaccines against Pandemic Influenza (Swine Flu and Avian Flu). BioOut is a forward-thinking contract testing organisation which has been inspected and approved to GMP standard by the UK MHRA. The company has wide experience of testing and releasing virus vaccine, including Pandemic and Seasonal flu, and provides the release testing of vaccine lots to meet the European Pharmacopeia release guidelines. BioOut has expertise in the handling of vaccine harvests and neutralisation of the virus lots for testing. In a relatively new innovation BioOut can offer an EP compliant alternative method to the lengthy and costly Mycoplasma test EP 2.6.1; PCR methodologies are used to detect mycoplasma, this can reduce the timelines for this test to 2 days rather than the 35 days this test would normally require and reduce costs by a factor of 4. Nexxus Scotland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009